How long should apixaban (Eliquis) be discontinued before spinal anesthesia in an adult with normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Apixaban (Eliquis) Discontinuation Before Spinal Anesthesia

For patients with normal renal function, discontinue apixaban at least 72 hours (3 days) before spinal anesthesia, and consider extending this to 5 days for very high-risk neuraxial procedures. 1

Recommended Hold Times

Standard Recommendation (Normal Renal Function, CrCl >80 mL/min)

  • Minimum: 72 hours (3 days) before neuraxial anesthesia 1
  • Preferred for spinal/epidural: Up to 5 days (120 hours) for very high hemorrhagic risk procedures like neuraxial blocks 1

The French GIHP guidelines explicitly classify neuraxial anesthesia as a "very high hemorrhagic risk" procedure requiring longer interruption times than standard surgeries. This is because spinal hematoma, though rare, can cause permanent paralysis—a catastrophic outcome that justifies extended caution.

Adjusted for Renal Impairment

While your question specifies normal renal function, be aware that:

  • CrCl 50-80 mL/min: 72 hours minimum 2
  • CrCl 30-50 mL/min: 96 hours (4 days) 2
  • CrCl 15-30 mL/min: Consider even longer intervals

Critical Context

Why Spinal Anesthesia Requires Longer Hold Times

Spinal and epidural anesthesia carry unique risks because:

  • Bleeding in the vertebral canal cannot be easily controlled surgically
  • Even small hematomas can cause spinal cord compression and permanent paralysis
  • The consequences are devastating and irreversible

The guidelines strongly recommend against performing neuraxial blocks if there is any possibility of residual apixaban concentration 1. This is particularly emphasized for elderly patients (>80 years) or those with renal impairment.

FDA Label Guidance

The FDA-approved Eliquis label states more conservatively: discontinue at least 48 hours prior to elective surgery or invasive procedures with moderate or high risk of bleeding 3. However, this is a general surgical recommendation and does not specifically address the heightened risk of neuraxial procedures.

Evidence Quality Considerations

The French GIHP guidelines 1 provide the most specific and conservative recommendations for neuraxial procedures, explicitly stating up to 5 days for apixaban before spinal/epidural anesthesia. The UK guidelines 2 recommend 24-48 hours for apixaban prophylaxis doses but acknowledge limited data for neuraxial blocks specifically.

Recent research 4 shows that 48-hour discontinuation achieves apixaban levels ≤30 ng/mL in 94% of patients for general surgery, but this study did not include neuraxial procedures. A case series 5 reported successful spinal anesthesia within 72 hours without complications, but this involved only elderly fracture patients where surgical urgency may have justified accepting higher risk.

Practical Algorithm

Step 1: Verify renal function (calculate CrCl using Cockcroft-Gault formula)

Step 2: Identify patient risk factors:

  • Age >80 years
  • Concurrent P-glycoprotein inhibitors (e.g., verapamil, amiodarone)
  • Concurrent CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin)

Step 3: Determine hold time:

  • Normal renal function (CrCl >80 mL/min), no risk factors: 72-120 hours (3-5 days)
  • Presence of risk factors: Extend to 5 days
  • Impaired renal function: Use adjusted times above

Step 4: Document the last dose timing precisely

Step 5: If urgent surgery is needed before adequate washout, consider:

  • Measuring apixaban-calibrated anti-Xa levels if available (target <30 ng/mL) 6, 4
  • Delaying procedure if possible
  • Using alternative anesthesia technique (general anesthesia)

Common Pitfalls to Avoid

  1. Don't rely on the 48-hour FDA recommendation for neuraxial procedures—this is insufficient for the unique risks of spinal hematoma 1

  2. Don't assume twice-daily dosing means faster clearance—apixaban has a 12-hour half-life, requiring multiple half-lives for adequate elimination 3

  3. Don't forget to check for drug interactions—P-gp and CYP3A4 inhibitors significantly prolong apixaban elimination 3

  4. Don't perform the block if timing is uncertain—when in doubt, delay or use general anesthesia 1

  5. Don't confuse prophylactic dosing (2.5 mg BID) with treatment dosing (5 mg BID)—though hold times are similar for neuraxial procedures, treatment doses carry higher baseline anticoagulation 2

Resumption After Procedure

Resume apixaban at least 6 hours after spinal needle placement or epidural catheter removal, and only after adequate hemostasis is confirmed 1. For procedures with ongoing bleeding risk, delay resumption further and consider bridging with prophylactic LMWH 1.

No bridging anticoagulation is needed during the 72-120 hour hold period for most patients 3, as the thrombotic risk during this brief interruption is generally acceptable compared to the catastrophic risk of spinal hematoma.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.